September 20, 2016
1150 Recent Articles
September 17, 2016
Backgrounds — The Less Said the Better
September 16, 2016
Substantial Evidence Supported Infringement of Limitations That Did Not Need Construction
September 16, 2016
PTAB Decision to Institute Despite Alleged § 315 Time Bar is Not Reviewable
September 13, 2016
Read Our Lips: Not Everything is Abstract
September 08, 2016
BioPharma Patents Quick Tips & News – November/December 2013 – Throwback Edition
September 06, 2016
The Intellectual Property Owner’s Manual
September 01, 2016
PTAB Reversed Based on Non-Analogous Art Theory
August 30, 2016
Federal Circuit Demonstrates Willingness to Rein in PTAB’s Onerous Idle Free Rules Regarding Claim Amendments
August 30, 2016
Claim Narrowed by Specification is Saved from Indefiniteness but too Narrow to be Infringed
August 30, 2016
Compliance with PTAB’s Requirements for Motion to Amend Arbitrary and Capricious?
August 24, 2016
45 Months of Inter Partes Review – By the Numbers
August 16, 2016
“Substantial Evidence” Hurdle is Substantially Difficult to Overcome
August 15, 2016
Broad Original Claims Prevent Invalidity for Lack of Adequate Written Description
August 11, 2016
PTAB Reversed–Common Sense Improperly Used to Supply Missing Limitation in Obviousness Inquiry
August 11, 2016
PTAB Misapplied Common Sense in Finding Claims Obvious
August 11, 2016
District Court Correctly Added Inventors Who Contributed to at least one Claim Element
August 09, 2016
BRI Does Not Apply if Patent Expires Any Time During Reexamination Proceeding
August 09, 2016
Federal Circuit Vacates and Remands PTAB Obviousness Determination Not Supported by Adequate Reasoned Explanation
August 05, 2016